...
首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >Noninvasive cardiac output monitoring with bioreactance as an alternative to invasive instrumentation for preclinical drug evaluation in beagles.
【24h】

Noninvasive cardiac output monitoring with bioreactance as an alternative to invasive instrumentation for preclinical drug evaluation in beagles.

机译:生物反应的无创心输出量监测可替代比格犬临床前药物评估的有创仪器。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Non-invasive measurement of cardiac output (CO) using bioreactance signals (NICOM) was recently validated in swine and human adults. The present study was designed to test the hypothesis that NICOM flow measurements can accurately measure CO and detect acute drug-induced changes in aortic blood flow (AoQ)>/=10% in beagles. METHODS: Data from 5 anesthetized, open chest beagles used for preclinical screening of novel neuromuscular blocking drugs were analyzed for the study. AoQ was measured beat-to-beat with a probe on the aortic root and averaged over 30s intervals. NICOM CO measurements were simultaneously obtained every 30s. NICOM precision (random variation) and accuracy relative to AoQ were assessed from individual segments of steady-state data. The ability of NICOM to detect acute alterations in AoQ>/=10% was determined from other segments with dynamic change. RESULTS: 516 simultaneous CO measurements between 826 and 2436 mL/min were analyzed. Steady-state measurements (20% of the dataset) revealed an average AoQ-NICOM difference (bias) of 63+/-38 mL/min, a percent error of 6.1%, and a NICOM precision of 6.1%. Within the acute change dataset, 21/23 events reflecting a >/=10% change in beat-to-beat AoQ were detected by the NICOM (sensitivity of 0.91). In none of 10 instances where drug or fluid injection altered AoQ<10% did the NICOM indicate a change (specificity of 1.0). DISCUSSION: Continuous, non-invasive measurement of CO by bioreactance provides data that satisfactorily approximates invasive measurement of aortic blood flow in beagles. In addition, despite a 30s interval between measurements, the NICOM appears to have sufficient fidelity to detect and quantify acute, drug-induced changes in CO. These data suggest that the NICOM may represent an alternative to open chest instrumentation for CO measurement in preclinical drug evaluation studies.
机译:简介:最近在猪和成人中使用生物反应信号(NICOM)进行了无创测量心输出量(CO)。本研究旨在验证以下假设:NICOM流量测量可以准确测量CO并检测比格犬中主动脉血流量(AoQ)> / = 10%的急性药物诱导的变化。方法:对5种麻醉的开胸小猎犬进行临床前筛查新型神经肌肉阻滞药的数据进行了分析。用主动脉根上的探头逐次测量AoQ,并在30s间隔内取平均值。每30秒同时获得NICOM CO测量值。从稳态数据的各个部分评估了NICOM的精度(随机变化)和相对于AoQ的精度。 NICOM检测到AoQ> == 10%的急性变化的能力是由具有动态变化的其他部分确定的。结果:分析了在826和2436 mL / min之间同时进行的516次CO测量。稳态测量(数据集的20%)显示,平均AoQ-NICOM差异(偏差)为63 +/- 38 mL / min,误差百分比为6.1%,NICOM精度为6.1%。在急性变化数据集中,通过NICOM检测到21/23个事件,反映了心跳之间的AoQ变化> / = 10%(灵敏度为0.91)。在10种药物或液体注射改变AoQ <10%的情况下,NICOM均未显示出变化(特异性为1.0)。讨论:通过生物反应连续,无创地测量CO可提供令人满意的近似比格犬主动脉血流的有创测量数据。此外,尽管两次测量之间的间隔为30秒,但NICOM似乎具有足够的保真度,可以检测和量化由药物引起的急性CO变化。这些数据表明,NICOM可以代替临床前药物中开放式胸腔测量CO评估研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号